| scholarly article | Q13442814 |
| P50 | author | Johan Åqvist | Q6255800 |
| Hugo Gutiérrez de Terán | Q37388229 | ||
| Martin Nervall | Q114440719 | ||
| P2093 | author name string | Ben M Dunn | |
| Jose C Clemente | |||
| P2860 | cites work | Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum | Q24597864 |
| MEROPS: the peptidase database | Q25255626 | ||
| Comparison of simple potential functions for simulating liquid water | Q26778447 | ||
| Anisotropic dynamics of the JE-2147-HIV protease complex: drug resistance and thermodynamic binding mode examined in a 1.09 A structure | Q27638669 | ||
| Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum | Q27640611 | ||
| Structural insights into the activation of P. vivax plasmepsin | Q27641327 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| Development and validation of a genetic algorithm for flexible docking | Q28236574 | ||
| Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine | Q28377023 | ||
| Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes | Q29397708 | ||
| Improved protein-ligand docking using GOLD | Q29616787 | ||
| Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine | Q30042887 | ||
| C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictions | Q31151933 | ||
| Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man. | Q33193846 | ||
| Binding affinity prediction with different force fields: examination of the linear interaction energy method | Q33202843 | ||
| Virtual screening for beta-secretase (BACE1) inhibitors reveals the importance of protonation states at Asp32 and Asp228. | Q33215820 | ||
| Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV. | Q33227803 | ||
| Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum | Q33255678 | ||
| Follow the protons: a low-barrier hydrogen bond unifies the mechanisms of the aspartic proteases | Q34401682 | ||
| Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor | Q34498794 | ||
| Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles. | Q34503862 | ||
| Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. | Q34548661 | ||
| The integration of genomic and structural information in the development of high affinity plasmepsin inhibitors | Q34999498 | ||
| A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparum | Q38527989 | ||
| The role of hydrogen bonding in the enzymatic reaction catalyzed by HIV-1 protease | Q42051224 | ||
| Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272. | Q43452863 | ||
| Ab initio molecular dynamics-based assignment of the protonation state of pepstatin A/HIV-1 protease cleavage site | Q43727557 | ||
| High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor | Q44511791 | ||
| Determination of the active site protonation state of beta-secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design | Q44704283 | ||
| A phenylnorstatine inhibitor binding to HIV-1 protease: geometry, protonation, and subsite-pocket interactions analyzed at atomic resolution. | Q44823661 | ||
| Modeling the protonation states of the catalytic aspartates in beta-secretase | Q45084450 | ||
| Search for substrate-based inhibitors fitting the S2' space of malarial aspartic protease plasmepsin II. | Q45165701 | ||
| Computation of affinity and selectivity: binding of 2,4-diaminopteridine and 2,4-diaminoquinazoline inhibitors to dihydrofolate reductases | Q47742338 | ||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5910-5916 | |
| P577 | publication date | 2006-10-05 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor | |
| P478 | volume | 580 |
| Q35660425 | Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin. |
| Q39162889 | Combined kinetic studies and computational analysis on kojic acid analogous as tyrosinase inhibitors. |
| Q47970644 | Computational analysis of aspartic protease plasmepsin II complexed with EH58 inhibitor: a QM/MM MD study |
| Q33961367 | Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design |
| Q27667575 | Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum |
| Q43180983 | Pyrrolidine derivatives as plasmepsin inhibitors: binding mode analysis assisted by molecular dynamics simulations of a highly flexible protein |
Search more.